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Introduction
Inguinal hernia is one of the most common diagnoses we encounter in our clinic. It has a high lifetime risk, around 27% in men and 3% in women (1) . In the USA, there are more than 700 000 hernia repairs performed each year (1) . Surgery for inguinal hernia repair has evolved over the centuries: from open surgery to laparoscopic minimally invasive repair, many techniques have been developed over time. Currently, tension-free mesh repair is the gold standard for hernia repair. Open Lichtenstein repair and laparoscopic mesh repair (using either the transabdominal preperitoneal or the totally extraperitoneal approach [TEP] ) are the most common repairs. These tension-free methods are easily reproducible in different surgical centers (2) . Both techniques have been shown to have similar clinical outcomes (3) (4) (5) .
These surgical techniques all require the placement of synthetic mesh inside the body. Since these procedures were introduced, many companies have tried to produce the improved meshes by using varying materials, construction methods, and geometry; they have reduced the amount of material used to minimize the foreign body reaction while at the same maintaining the mesh's tensile strength and surgical handling. As a result, there are more than a dozen meshes available on the market.
There have been reports and animal studies on individual meshes, but direct comparisons between them and related clinical results have been scare. In this study, we compared the surgical handling and clinical outcomes of two meshes used in laparoscopic TEP inguinal hernia repair. One mesh, ULTRAPRO™ (Ethicon), is partially absorbable and made of nonabsorbable polypropylene (Prolene; Ethicon) mixed with an absorbable material poliglecaprone 25 (Monocryl; Ethicon) in a single-sheet form. It is a lightweight mesh that weighs 28 g/m 2 . The other mesh, Parietex™ (Tyco Healthcare, Hongkong), is a woven polyester multifilament mesh that was anatomically designed; it has a slit over lateral side to accommodate the spermatic cord. It is a heavyweight mesh that weighs 116 g/m 2 ( Table 1) .
Materials and Methods
This was a single-center, prospective randomized controlled trial to compare the surgical handling and clinical outcome between ULTRAPRO and Parietex. All laparoscopic TEP inguinal hernia repairs were performed at the Pamela Youde Nethersole Eastern Hospital. This study protocol was approved by the Institutional Review Board of the Hong Kong East Cluster Health Service in 2009 (reference number: 2009-087). The study was also registered in the Australian New Zealand Clinical Trial Registry (registration no: ACTRN12610000031066). Each patient's decision to join this study was voluntary; informed consent was obtained from each, and none was financially compensated. Randomization to the ULTRAPRO and Parietex groups occurred after informed consent was received.
We recruited patients who met the following criteria: (i) aged 18-81 years; (ii) diagnosed with primary inguinal hernia; (iii) medically fit for general anesthesia; and (iv) a suitable candidate for laparoscopic TEP repair.
Patients were excluded in the following circumstances: (i) physical examination indicated that their hernia that could not be completely reduced; (ii) they had an inguino-scrotal hernia; (iii) sliding hernia was suspected; (iv) they had a lower abdominal scar over the operative region; (v) they were taking an anticoagulant; (vi) they had bleeding diathesis; or (vii) they had chronic liver disease with ascites or portal hypertension.
Eligible patients were randomized into one of two treatment groups for their laparoscopic TEP inguinal hernia repair: the ULTRAPRO group and the Parietex™ group. Patients were randomized just before the surgery, when the operating surgeon received a sealed opaque envelope that contained the type of mesh to be used.
All participating surgeons had participated in at least 50 laparoscopic TEP inguinal hernia repairs before the commencement of the study. All hernia repairs were performed in a standardized way agreed by all surgeons before the study began.
Operative technique
For surgery, patients were placed in a supine Trendelenburg position, and a urinary catheter was inserted after general anesthesia was administered. A preoperative antibiotic (amoxicillin Na 1 g with clavulanate K 200 mg) was given intravenously on induction of the general anesthesia, as long as the patient had no allergy. A three-port technique was used. This involved an infraumbilical access to the preperitoneal space and then insufflation with CO 2 to a pressure of 10 mmHg. With a 0 10-mm laparoscope (ENDOEYE; Olympus Medical System Corporation, Hongkong) and two 5-mm laparoscopic graspers, the hernial sac was reduced, and the preperitoneal space was opened sufficiently to place a 10 × 15-cm mesh. The assigned mesh was then placed in the preperitoneal plane. No device or agent was used to anchor the mesh.
Outcome measures
All patients had a follow-up at the outpatient clinic 2 weeks after discharge. Subsequent follow-ups were scheduled at 6 and 12 months in the first year and then annually thereafter. Patient demographics, hernia characteristics, operation times, mesh manipulating times, lengths of hospital stay, and perioperative complications were recorded for analysis. Length of hospital stay was the total number of days spent in the hospital after the surgery. Perioperative complication was defined by the presence of urinary retention, seroma or hematoma formation, and infection. During follow-up, all complications and clinical recurrences were recorded. Surgeons assigned to do the postoperative assessment were blind to the type of mesh used. Foreign body sensation and chronic postoperative neuralgia was assessed at 12 months after the operation. Chronic postoperative neuralgia was defined by the presence of intermittent hyperesthesia, burning sensation, and/or jabbing pain in the ipsilateral inguinal area. The pain assessment included questions about pain at rest and when coughing, rising from a lying to sitting position, and exercising. If pain was indicated, the severity of the pain was graded on a visual analog scale ranging from 0 (no pain) to 10 (worst pain). Any foreign body sensation after the operation when coughing, rising from a lying to sitting position, and exercising was recorded. The severity of the foreign body sensation was graded on a scale ranging from 0 (least discomfort) to 5 (most severe discomfort).
The primary end-point was mesh manipulating time. The secondary end-points were hernia recurrence rate, perioperative complication rate, length of hospital stay, and incidence of chronic postoperative neuralgia and foreign body sensation.
Statistical analysis
The sample size calculation was based on that assumption of a mean difference of 10% in mesh manipulating times between the two groups. This difference was considered clinically significant, and a sample size of 72 (36 in each group) was needed to prove this difference (α set at 0.05; β set at 0.2; power = 80%). If there was 10% loss during follow-up, a total sample size of 80 (40 in each group) was needed.
Statistical calculations were performed using the χ 2 test or Fisher's exact test for categorical variables; continuous variables were compared by the Mann-Whitney Utest. P < 0.05 was considered statistically significant.
Results
From October 2009 to August 2011, 58 eligible patients were recruited for this study, as were 27 patients with bilateral inguinal hernia. Ultimately, this study included 85 patients who underwent laparoscopic TEP inguinal hernia repair at the Pamela Youde Nethersole Eastern Hospital. Forty-three were randomized into the ULTRA-PRO group, and 42 were allocated to the Parietex group ( Figure 1 ). Their ages ranged from 27 years old to 81 years old. The male-to-female ratio was 55 to 3. Each mesh group lost four patients to follow-up; all were excluded from the analysis. The mean follow-up time was 20.3 months (range: 12-34 months). There were 20 direct hernias and 15 indirect hernias in the ULTRA-PRO group, and there were 17 direct hernias and 20 indirect hernias in the Parietex group. Four patients in the ULTRAPRO group and one in the Parietex group had combined direct and indirect hernias. There were no significant differences in patient demographics between the two groups ( Table 2 ). The mean mesh handling time was 152 s (range: 41-360 s) for the ULTRAPRO group and 206 s (range: 110-540 s) for the Parietex group; this difference was statistically significant (P = 0.001). The median of length of hospital stay in both group was 0 days (range: 0-2 days), which was not significant. Three patients developed urinary retention in the ULTRAPRO group, and none in the Parietex group did; this difference was not statistically significant. Two patients in the ULTRA-PRO group and nine in the Parietex group developed seroma; this difference was statistically significant difference (P = 0.02). Postoperative infection did not occur in either group. In the ULTRAPRO, there was one case of hernia recurrence at 9 months postoperatively and another at 12 months; there was no significant difference in recurrence between the groups. The overall recurrence rate was 2.5% (Table 3) . Both group had similar results with regard to postoperative foreign body sensation and discomfort sensation in different positions, but there was no significant difference between the groups (Table 4) .
Discussion
In the present study, the flat mesh, ULTRAPRO, required significantly less time to manipulate the mesh than did the anatomical mesh, Parietex (P = 0.001). This is because, with the Parietex, more time is needed to free the spermatic cord so the lower part of the mesh can pass it posteriorly. However, surgeon feedback indicated that they generally felt more secure with the anatomical mesh than the simple flat mesh. The difference in manipulations times was small-less than 1 min-so mesh choice may not have much clinical significance on the overall operating time.
It is believed that mesh repair induces a chain of inflammatory responses over the hernia site, and as a result, a strong mesh aponeurosis scar tissue complex forms to strengthen the weakened native tissue (6). However, a persistent inflammatory response can result in chronic pain (7) . These issues led to the development of lightweight mesh, which has better biocompatibility then heavyweight mesh. However, it does not always weaken the inflammatory response sufficiently to enable mesh aponeurosis scar tissue complex formation (6) .
Some previous studies showed a higher hernia recurrence rate with the use lightweight mesh than with heavyweight mesh (8, 9) . We had similar results in the present study, although the difference between the groups was not statistically significant (P = 0.157). There is no consensus on why there is a difference in recurrence rate. However, some have purposed that lightweight mesh is less stiff than heavyweight mesh, so it tends to migrate during desufflation, leading to a higher hernia recurrence rate (9) .
We also found that the seroma formation rate was higher in Parietex group than in the ULTRAPRO group, a statistically significant difference (P = 0.02). We believe that because the Parietex mesh has a smaller pore size (1.2 × 1.6 mm) than the ULTRAPRO mesh (3 × 4 mm), it creates a denser, more waterproof barrier. In addition, the Parietex wraps more securely around the spermatic cord and overlaps itself on its lateral part, thus preventing the reabsorption of seroma fluid.
Many experts believe that lightweight mesh offers better clinical outcomes than heavyweight mesh in terms of postoperative pain and foreign body sensation. With its larger pore size, lightweight mesh theoretically should induce a smaller inflammatory response, less scar tissue formation, and therefore, less postoperative pain. This belief has been supported by a previous randomized controlled trial (10) . However, the recently published meta-analysis by Currie et al., which included eight randomized controlled trials, showed no difference between short-and long-term outcomes of lightweight and heavyweight mesh with regard to postoperative pain (11). Our study is consistent with the report by Currie et al.: there was no significant difference in postoperative discomfort and foreign body sensation between the two mesh groups, regardless of body position. The mean follow-up time in our study was 20.3 months.
A recent large-scale, double-blind, randomized trial from the Netherlands, the TULP-trial, had similar results as well. It is found no significant differences between lightweight and heavyweight mesh in the incidence of postoperative pain and foreign body sensation during a 2-year follow-up. Burgmans et al. proposed that the underlying reason for this was the lack of direct contact with the sensory nerve, which reduces the risk of nerve damage during preperitoneal dissection and mesh placement by the peritoneum (12, 13) .
Conclusion
Flat mesh (ULTRAPRO) required less manipulating time than the anatomical mesh (Parietex) during TEP, but the difference was small. Lightweight and heavyweight mesh have similar outcomes with regard to discomfort sensation and foreign body sensation in long-term follow-up. Ideally, future randomized controlled trials will compare different meshes based on their material, weight, design, and construction method. This will enable both surgeons and patients to choose a mesh based on scientific evidence.
